NCT00673062

Study of the Effect of SCH 900538 on Congestion in Subjects With Seasonal Allergic Rhinitis (Study P05031)(COMPLETED)

Study of the Decongestant Effect of SCH 900538 Compared With Placebo and Pseudoephedrine as Active Control in Subjects With Seasonal Allergic Rhinitis (SAR) Exposed to Pollen in an Environmental Exposure Unit

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 265 (actual)
• Sponsor: Merck Sharp & Dohme LLC · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This study is to evaluate the effectiveness of a new drug on congestion in subjects with seasonal allergic rhinitis. This effect will be compared to placebo and to the decongestant, pseudoephedrine.

Conditions

• Seasonal Allergic Rhinitis

Interventions

Type	Name	Description
DRUG	SCH 900538	(4X50mg Capsules)
DRUG	Pseudoephedrine	Encapsulated pseudoephedrine (2X30 mg immediate release tablets)
DRUG	Placebo Capsules	Placebo

Timeline

• Start date: 2008-05-01
• Primary completion: 2008-07-01
• Completion: 2008-07-01
• First posted: 2008-05-07
• Last updated: 2015-11-02